Cargando…

Beta-Amyloid (Aβ(1-42)) Increases the Expression of NKCC1 in the Mouse Hippocampus

Alzheimer’s disease (AD) is a neurodegenerative disorder with an increasing need for developing disease-modifying treatments as current therapies only provide marginal symptomatic relief. Recent evidence suggests the γ-aminobutyric acid (GABA) neurotransmitter system undergoes remodeling in AD, disr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lam, Patricia, Vinnakota, Chitra, Guzmán, Beatriz Calvo-Flores, Newland, Julia, Peppercorn, Katie, Tate, Warren P., Waldvogel, Henry J., Faull, Richard L. M., Kwakowsky, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027496/ https://www.ncbi.nlm.nih.gov/pubmed/35458638 http://dx.doi.org/10.3390/molecules27082440

Ejemplares similares

The Acute Effects of Amyloid-Beta(1–42) on Glutamatergic Receptor and Transporter Expression in the Mouse Hippocampus
por: Yeung, Jason H. Y., et al.
Publicado: (2020)

Amyloid-Beta(1-42) -Induced Increase in GABAergic Tonic Conductance in Mouse Hippocampal CA1 Pyramidal Cells
por: Calvo-Flores Guzmán, Beatriz, et al.
Publicado: (2020)

An α5 GABAA Receptor Inverse Agonist, α5IA, Attenuates Amyloid Beta-Induced Neuronal Death in Mouse Hippocampal Cultures
por: Vinnakota, Chitra, et al.
Publicado: (2020)

The Interplay Between Beta-Amyloid 1–42 (Aβ(1–42))-Induced Hippocampal Inflammatory Response, p-tau, Vascular Pathology, and Their Synergistic Contributions to Neuronal Death and Behavioral Deficits
por: Calvo-Flores Guzmán, Beatriz, et al.
Publicado: (2020)

Treatment of beta amyloid 1–42 (Aβ(1–42))-induced basal forebrain cholinergic damage by a non-classical estrogen signaling activator in vivo
por: Kwakowsky, Andrea, et al.
Publicado: (2016)

Cation-Chloride Cotransporters KCC2 and NKCC1 as Therapeutic Targets in Neurological and Neuropsychiatric Disorders
por: Lam, Patricia, et al.
Publicado: (2023)

The effects of amyloid-beta on hippocampal glutamatergic receptor and transporter expression
por: Kwakowsky, Andrea, et al.
Publicado: (2020)

Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease
por: Govindpani, Karan, et al.
Publicado: (2017)

Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target
por: Govindpani, Karan, et al.
Publicado: (2019)

Vascular Dysfunction in Alzheimer’s Disease: A Prelude to the Pathological Process or a Consequence of It?
por: Govindpani, Karan, et al.
Publicado: (2019)

GABA(A) Receptors Are Well Preserved in the Hippocampus of Aged Mice
por: Palpagama, Thulani H., et al.
Publicado: (2019)

mGluR1α expression in the hippocampus, subiculum, entorhinal cortex and superior temporal gyrus in Alzheimer’s disease
por: Yeung, J.H.Y., et al.
Publicado: (2022)

Gamma-aminobutyric acid A receptors in Alzheimer's disease: highly localized remodeling of a complex and diverse signaling pathway
por: Kwakowsky, Andrea, et al.
Publicado: (2018)

Glutamatergic receptor expression changes in the Alzheimer's disease hippocampus and entorhinal cortex
por: Yeung, Jason H. Y., et al.
Publicado: (2021)

The effect of age and sex on the expression of GABA signaling components in the human hippocampus and entorhinal cortex
por: Ethiraj, Jayarjun, et al.
Publicado: (2021)

The effect of repeated stress on KCC2 and NKCC1 immunoreactivity in the hippocampus of female mice
por: Tsukahara, Takao, et al.
Publicado: (2016)

EAAT2 Expression in the Hippocampus, Subiculum, Entorhinal Cortex and Superior Temporal Gyrus in Alzheimer’s Disease
por: Yeung, Jason H. Y., et al.
Publicado: (2021)

Secreted Amyloid Precursor Protein Alpha (sAPPα Regulates the Cellular Proteome and Secretome of Mouse Primary Astrocytes
por: Peppercorn, Katie, et al.
Publicado: (2023)

Therapeutic potential of alpha 5 subunit containing GABA(A) receptors in Alzheimer’s disease
por: Kwakowsky, Andrea, et al.
Publicado: (2021)

NKCC1 and NKCC2: The pathogenetic role of cation-chloride cotransporters in hypertension
por: Orlov, Sergei N., et al.
Publicado: (2015)

Secreted Amyloid Precursor Protein Alpha, a Neuroprotective Protein in the Brain Has Widespread Effects on the Transcriptome and Proteome of Human Inducible Pluripotent Stem Cell-Derived Glutamatergic Neurons Related to Memory Mechanisms
por: Peppercorn, Katie, et al.
Publicado: (2022)

Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer’s Disease
por: Kwakowsky, Andrea, et al.
Publicado: (2016)

iGluR expression in the hippocampal formation, entorhinal cortex, and superior temporal gyrus in Alzheimer’s disease
por: Yeung, Jason HY, et al.
Publicado: (2022)

CSF beta-amyloid 1–42 – what are we measuring in Alzheimer's disease?
por: Hu, William T, et al.
Publicado: (2015)

Oligomeric Forms of Human Amyloid-Beta(1–42) Inhibit Antigen Presentation
por: Gericke, Christoph, et al.
Publicado: (2020)

The Role of Age on Beta-Amyloid(1–42) Plasma Levels in Healthy Subjects
por: Zecca, Chiara, et al.
Publicado: (2021)

The HSP40 chaperone Ydj1 drives amyloid beta 42 toxicity
por: Ring, Julia, et al.
Publicado: (2022)

The Role of Microglia and Astrocytes in Huntington’s Disease
por: Palpagama, Thulani H., et al.
Publicado: (2019)

Tyramine and Amyloid Beta 42: A Toxic Synergy
por: Dhakal, Sudip, et al.
Publicado: (2020)

AFM Probing of Amyloid-Beta 42 Dimers and Trimers
por: Maity, Sibaprasad, et al.
Publicado: (2020)

Amyloid-Beta 1-42 Cross-Reactive Antibody Prevalent in Human Sera May Contribute to Intraneuronal Deposition of A-Beta-P-42
por: Vojdani, Aristo, et al.
Publicado: (2018)

Nasal mucosal inhalation of amyloid-beta peptide 3–10 defective adenovirus attenuates cytotoxicity induced by beta-amyloid (1–42)
por: Jiang, Tongzi, et al.
Publicado: (2014)

Impaired Expression of GABA Signaling Components in the Alzheimer’s Disease Middle Temporal Gyrus
por: Govindpani, Karan, et al.
Publicado: (2020)

Neuroprotective Effect of Caffeine in Alzheimer’s Disease
por: M Yelanchezian, Y Mukish, et al.
Publicado: (2022)

Emergence of Alternative Structures in Amyloid Beta 1-42 Monomeric Landscape by N-terminal Hexapeptide Amyloid Inhibitors
por: Chakraborty, Srirupa, et al.
Publicado: (2017)

Automation vs. Experience: Measuring Alzheimer’s Beta-Amyloid 1–42 Peptide in the CSF
por: Kollhoff, Alexander L., et al.
Publicado: (2018)

Hyperoside protects the blood-brain barrier from neurotoxicity of amyloid beta 1–42
por: Liu, Chen-Yang, et al.
Publicado: (2018)

Development of an Immunoassay for the Detection of Amyloid Beta 1-42 and Its Application in Urine Samples
por: Wongta, Anurak, et al.
Publicado: (2020)

Detection of Alzheimer's disease amyloid beta 1‐42, p‐tau, and t‐tau assays
por: van Harten, Argonde C., et al.
Publicado: (2021)

Hypochlorite-induced oxidation promotes aggregation and reduces toxicity of amyloid beta 1-42
por: Mañucat-Tan, Noralyn B., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hr14h331cu8ij353r704nq21de